Sorafenib Market Report - Industry Outlook - Latest Development and Trends 2025


21 January 2019 - Global Sorafenib Market is classified on the basis of treatment and geography. Sorafenib (Nexavar) is an orally-active multikinase inhibitor. It blocks the action of an abnormal protein that indicates cancer cells to grow. This slows down or stops the growth of cancer cells (tumors). It also slows down the growth of new-fangled blood vessels within the tumor.

Sorafenib is used for treating advanced renal cell carcinoma (RCC is a kind of cancer that begins with the kidneys). Sorafenib is also used for treating hepatocellular carcinoma (a kind of liver cancer) that can’t be treated with surgery and a certain kind of thyroid cancer that has spread to the other parts of the body and can’t be treated with radioactive iodine. Sorafenib may cause side effects such as tiredness, weakness, skin redness, hair loss, itching, dry or peeling skin, loss of appetite, constipation, diarrhoea, dry mouth, weight loss, joint pain, numbness, pain or tingling in hands or feet and headache.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/sorafenib-market

In addition, some side effects can be serious such as unusual bruising or bleeding, black or tarry stools, bloody vomit, chest pain, confusion, changes in vision, dark urine, red blood in stools, vomiting material that looks like coffee grounds, severe stomach pain, shortness of breath, dizziness, sudden severe headache, seizures, mouth sores, yellowing of the skin or eyes, etc. The key factor that propels the growth of the Sorafenib Market includes increasing prevalence of cancer.

On the other hand, there are also factors that may hamper the growth of the market such as various side effects like loss, of appetite, seizures, dark urine, chest pain, and so on. Sorafenib Market is classified on the basis of treatment as advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer. Sorafenib Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.

The North American region comprises the U.S., and Canada. Latin America region comprises Mexico and Brazil. The Western European region comprises Germany, Italy, France, England and Spain. The Eastern European region comprises Poland and Russia. Asia Pacific region comprises China, India, ASEAN, Australia & New Zealand. The Middle East and Africa region comprises GCC, South Africa and North Africa.

Some of the key players that fuel the growth of the Sorafenib Market include Pfizer, Allergan, Alnylam Pharmaceuticals, Amgen, Angstrom Pharmaceuticals, Hetero Drugs, ImClone Systems, Intas Pharmaceuticals, Kyowa Hakko Kirin, Levolta Pharmaceuticals, Mabtech, Marsala Biotech, Neumedicines, Novartis, Oncobiologics, Acceleron Pharma, Biocon, Bionomics, CASI Pharmaceuticals, Celgene Corporation, Enzon Pharmaceuticals, Five Prime Therapeutics, Fujifilm Kyowa Kirin Biologics, Genentech, Genexine, Onyx Pharmaceuticals, and others.

Market Segment:

The major manufacturers covered in this report

• Pfizer
• Allergan
• Alnylam Pharmaceuticals
• Acceleron Pharma
• Biocon
• Bionomics
• CASI Pharmaceuticals
• Celgene Corporation
• Enzon Pharmaceuticals
• Five Prime Therapeutics
• Fujifilm Kyowa Kirin Biologics
• Genentech
• Genexine
• Hetero Drugs
• ImClone Systems
• Intas Pharmaceuticals
• Levolta Pharmaceuticals
• Mabtech

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/sorafenib-market/request-sample


Comments

Post a Comment

Popular posts from this blog

Advancing Hydrogen Production Through Next Generation Electrolyzer Technologies

  Electrolyzers are at the center of the global transition toward clean energy and decarbonization. By using electricity to split water into hydrogen and oxygen, electrolyzers enable the production of green hydrogen when powered by renewable sources such as solar and wind. As governments and industries seek alternatives to fossil fuels, electrolyzer technology is rapidly evolving to deliver higher efficiency, scalability, and cost effectiveness. Hydrogen produced through electrolysis offers significant potential for decarbonizing hard to abate sectors including heavy industry, transportation, and power generation. Unlike conventional hydrogen production methods that rely on natural gas reforming, electrolyzers provide a pathway to low carbon hydrogen, supporting climate goals and long term energy security. Technology Advancement Across Electrolyzer Several electrolyzer technologies are currently shaping the industry, each offering distinct advantages. Alkaline electrol...
Read more

Drug Discovery Outsourcing Driving Faster Innovation and Smarter R&D Strategies

  Drug discovery outsourcing has emerged as a strategic approach for pharmaceutical and biotechnology companies seeking to enhance efficiency, reduce costs, and accelerate innovation. As therapeutic research becomes increasingly complex, organizations are turning to specialized external partners to manage critical aspects of the discovery pipeline. By leveraging advanced technologies, global expertise, and scalable infrastructure, outsourcing has become a cornerstone of modern drug development strategies. The early stages of drug development require significant investment in target identification, lead optimization, preclinical testing, and regulatory documentation. Managing these processes internally can strain resources and extend development timelines. Drug discovery outsourcing allows companies to access experienced scientific teams, state of the art laboratories, and advanced analytical tools without bearing the full burden of capital expenditure. Benefits of Out...
Read more

How Urbanization and Mega Infrastructure Projects Are Driving Ferrosilicon Demand

  Ferrosilicon is a vital alloy composed primarily of iron and silicon, widely used in steelmaking and foundry applications. It plays a critical role as a deoxidizer and alloying element, enhancing the strength, durability, and corrosion resistance of steel and cast iron. Produced in electric arc furnaces through the reduction of silica with coke in the presence of iron, ferrosilicon remains indispensable to modern industrial development. As global construction, manufacturing, and clean energy initiatives accelerate, the demand for ferrosilicon continues to evolve in response to changing industrial priorities. Infrastructure and Urbanization Driving Demand Rapid urbanization and infrastructure expansion across emerging and developed economies are key drivers of ferrosilicon consumption. Governments worldwide are investing heavily in transportation networks, smart cities, bridges, residential complexes, and industrial corridors. These projects require substantial volume...
Read more